HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Caroline J Springer Selected Research

gamma-Glutamyl Hydrolase (Carboxypeptidase G2)

11/2009Hyperpolarized (13)C magnetic resonance detection of carboxypeptidase G2 activity.
7/2008Attenuated Salmonella targets prodrug activating enzyme carboxypeptidase G2 to mouse melanoma and human breast and colon carcinomas for effective suicide gene therapy.
5/2007Suicide gene therapy of human colon carcinoma xenografts using an armed oncolytic adenovirus expressing carboxypeptidase G2.
6/2005Systemic gene-directed enzyme prodrug therapy of hepatocellular carcinoma using a targeted adenovirus armed with carboxypeptidase G2.
3/2002Three new prodrugs for suicide gene therapy using carboxypeptidase G2 elicit bystander efficacy in two xenograft models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Caroline J Springer Research Topics

Disease

25Neoplasms (Cancer)
11/2019 - 03/2002
13Melanoma (Melanoma, Malignant)
03/2013 - 04/2004
4Carcinoma (Carcinomatosis)
07/2008 - 03/2002
3Breast Neoplasms (Breast Cancer)
11/2019 - 03/2002
3Sarcoma (Soft Tissue Sarcoma)
09/2010 - 06/2008
2Carcinogenesis
01/2012 - 01/2010
1Renal Cell Carcinoma (Grawitz Tumor)
01/2016
1Neoplasm Metastasis (Metastasis)
12/2012
1Hypoxia (Hypoxemia)
12/2012
1Keratoacanthoma
01/2012
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2012
1Colonic Neoplasms (Colon Cancer)
05/2011
1Colorectal Neoplasms (Colorectal Cancer)
08/2010
1Hepatocellular Carcinoma (Hepatoma)
06/2005

Drug/Important Bio-Agent (IBA)

10EnzymesIBA
11/2009 - 03/2002
10ProdrugsIBA
11/2009 - 03/2002
6Pharmaceutical PreparationsIBA
01/2016 - 06/2005
5Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
03/2013 - 01/2006
5gamma-Glutamyl Hydrolase (Carboxypeptidase G2)IBA
11/2009 - 03/2002
4Phosphotransferases (Kinase)IBA
09/2010 - 03/2004
3Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2016 - 04/2004
3Glutamic Acid (Glutamate)FDA Link
04/2014 - 03/2002
3DNA (Deoxyribonucleic Acid)IBA
10/2010 - 08/2004
3Serine (L-Serine)FDA Link
09/2010 - 08/2004
3Protein Kinases (Protein Kinase)IBA
09/2010 - 08/2004
3Threonine (L-Threonine)FDA Link
09/2010 - 08/2004
2Biomarkers (Surrogate Marker)IBA
11/2019 - 05/2011
2Sunitinib (Sutent)FDA Link
01/2016 - 12/2012
2VemurafenibIBA
02/2013 - 01/2012
2Telomerase (Telomerase Reverse Transcriptase)IBA
05/2007 - 06/2005
2beta-Galactosidase (Lactaid)IBA
04/2003 - 03/2002
1CollagenIBA
11/2019
1Collagenases (Collagenase)FDA Link
11/2019
1pazopanibFDA Link
01/2016
1Tyrosine Kinase InhibitorsIBA
01/2016
1trametinibIBA
01/2016
1SolutionsIBA
04/2014
1Drug CombinationsIBA
02/2013
1dabrafenibIBA
02/2013
1Glucose (Dextrose)FDA LinkGeneric
12/2012
1PLX 4720IBA
01/2012
1AcidsIBA
05/2011
1pyrazoleIBA
09/2010
1Proto-Oncogene Proteins B-rafIBA
07/2009
1imidazoloneIBA
04/2009
1VNP 20009 (VNP20009)IBA
07/2008
1PyrazinesIBA
06/2008
1ZD 2767IBA
05/2007
1antineoplaston A10 (A 10)IBA
11/2006
1glutamate carboxypeptidaseIBA
03/2002
14- ((2- chloroethyl)(2- mesyloxyethyl)amino)benzoylglutamic acid (CMDA)IBA
03/2002

Therapy/Procedure

9Therapeutics
11/2019 - 05/2005
2Drug Therapy (Chemotherapy)
11/2009 - 12/2006
1Intravenous Injections
12/2012
1Oral Administration
10/2010